The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.
Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.
The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.
The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.
| Summaries of Product Characteristics 121 - 150 of 186 |
|
|
|
Package
leaflet | Status for
supply | Name of the medicinal product |
|
PL
|
Resepti
|
Innovair 100-6 mikrog-annos inhalaatiosumute SPC 2023-10-31
|
|
PL
|
Resepti
|
Innovair 200 mikrog-6 mikrog-annos inhalaatiosumute SPC 2023-10-31
|
|
PL
|
Resepti
|
Innovair nexthaler 100 mikrog-6 mikrog-inhalaatio inhalaatiojauhe SPC 2022-09-01
|
|
PL
|
Resepti
|
Innovair Nexthaler 200 mikrog-6 mikrog - inhalaatio inhalaatiojauhe SPC 2022-01-25
|
|
|
|
European Medicines Agency's website:
INOmax - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Inovelon - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Inrebic - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Inspiolto Respimat 2.5 mikrog-2.5 mikrog inhalaationeste, liuos SPC 2022-08-12
|
|
PL
|
Resepti
|
Inspra 25 mg, 50 mg tabletti, kalvopäällysteinen SPC 2021-04-07
|
|
|
|
European Medicines Agency's website:
Instanyl - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Instillido 20 mg/ml geeli SPC 2023-10-24
|
|
|
|
European Medicines Agency's website:
Insulatard - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Insulin aspart Sanofi - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Insulin lispro Sanofi - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Insuman - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Integrilin - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Intelence - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Intrarosa - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Intuniv - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Invanz - EMA: EPAR PI
Finnish Swedish
|
|
|
|
European Medicines Agency's website:
Invega - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Invicorp 25 mikrog - 2 mg injektioneste, liuos SPC 2023-07-12
|
|
|
|
European Medicines Agency's website:
Invokana - EMA: EPAR PI
Finnish Swedish
|
|
PL
|
Resepti
|
Iomeron 150mg I-ml, 200mg I-ml, 250mg I-ml, 300mg I-ml, 350mg I-ml ja 400 mg I-ml injektioneste SPC 2023-08-18
|
|
PL
|
Resepti
|
Iopamigita 300 mg-ml injektio-infuusioneste SPC 2011-09-07
|
|
PL
|
Resepti
|
Iopidine 10 mg-ml silmätipat, liuos, kerta-annospakkaus SPC 2022-07-25
|
|
PL
|
Resepti
|
Iopidine 5 mg-ml silmätipat, liuos SPC 2022-07-25
|
|
PL
|
Resepti
|
Ipratropium bromide/salbutamol Neutec 0,5 mg / 2,5 mg per 2,5 ml sumutinliuos SPC 2023-07-31
|
|
PL
|
Resepti
|
Ipratropium-Salbutamol Orion 0.5 mg-2.5 mg per 2.5 ml sumutinliuos SPC 2024-01-15
|
|
PL
|
Resepti
|
Iqymune 100 mg-ml infuusioneste, liuos SPC 2022-08-01
|
|
|
